The FDA has approved TNKase, a new, fast-acting stroke treatment that dissolves blood clots more efficiently, marking a significant advancement in stroke therapy and clot-busting technology.
Researchers at Karolinska Institutet have identified a new mechanism that may improve the treatment of ischemic stroke. The ...
Katie Brett's sister Sasha Marsden was just 16 when she was stabbed to death by David Minto, he was given a minimum term of ...
The FDA has approved TNKase, a tissue plasminogen, clot-dissolving agent, to treat acute ischemic stroke in adults, according ...
This quick daily habit may reduce the risk of stroke and other heart conditions, a new study reveals
When we think of ways to protect our hearts, diet and exercise often come to mind first. But while doing enough cardio and ...
Ischemic stroke continues to rank among the top causes of death and long-term disability globally. While advances in acute treatments like clot retrieval and thrombolysis have improved outcomes, the ...
Discover the five critical stages of hypertension from normal to high crisis, learn warning signs, and find out when you need ...
February is American Heart Month. And what better time to talk about heart health? Did you know heart disease claims a life ...
Blood clotting disorders can be inherited or acquired. Some types cause excessive bleeding, while others cause excessive ...
According to Roche subsidiary Genentech, which announced the label expansion on Monday, TNKase is the first new drug for ...
“The perception is that the only people who have strokes are older people. You know, 60, 70, 80, 90. However, about 18 percent of strokes happen in young people, and this percentage is rising,” Dr.
Ballad Health will host a Neurosciences Symposium on Friday. The symposium will feature experts in stroke treatment, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback